Adial Pharmaceuticals (ADIL)
(Delayed Data from NSDQ)
$1.70 USD
-0.16 (-8.60%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $1.73 +0.03 (1.76%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.51 | 0.00% |
Earnings Summary
For their last quarter, Adial Pharmaceuticals (ADIL) reported earnings of -$1.14 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for ADIL's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.51 per share, reflecting a year-over-year increase of 81.45%.
Earnings History
Price & Consensus
Zacks News for ADIL
All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
ADIL: What are Zacks experts saying now?
Zacks Private Portfolio Services